Expert Practice in Hematology

Meeting Overview

On behalf of Aristoteles Giagounidis, MD, PhD, meeting chairman, we are pleased to invite you to the Expert Practice^SM in Hematology meeting in Lisbon, Portugal, on 25 September 2010.

During this case-based meeting, leaders in the field will discuss, in an interactive format, clinical issues encountered daily by practicing physicians.

For available travel grants, please contact: travelgrants@prIMEoncology.org.

Target Audience
This activity is designed for hematologists, medical oncologists, radiation oncologists, and other healthcare providers involved and/or interested in the management of patients with hematologic malignancies.

Meeting Venue
Sofitel Lisbon Liberdade Avenida Da Liberdade 127 1269-038 Lisbon, Portugal

Faculty
Chair Aristoteles Giagounidis, MD, PhD St Johannes Hospital Duisburg, Germany Faculty Drew Provan, MD, FRCP, FRCPath The Royal London Hospital London, United Kingdom Mathias Rummel, MD, PhD University of Giessen Giessen, Germany Evangelos Terpos, MD, PhD University of Athens Athens, Greece Thorsten Zenz, MD University of Ulm Ulm, Germany

Agenda

Friday, 24 September 2010
20.00		Reception and buffet dinner
Saturday, 25 September 2010
09.00		Welcome and demographic questions Aristoteles Giagounidis, MD, PhD
09.20		Case #1—Mantle cell lymphoma Mathias Rummel, MD, PhD
09.55		Case #2—Low-risk myelodysplastic syndromes Aristoteles Giagounidis, MD, PhD
10.30		Break
11.00		Case #3—Immune thrombocytopenia: Shifting focus in management Drew Provan, MD, FRCP, FRCPath
11.35		Case #4—High-risk myelodysplastic syndromes Aristoteles Giagounidis, MD, PhD
12.10		Case #5—Chronic lymphocytic leukemia: Improving outcomes with novel treatments Thorsten Zenz, MD
12.45		Lunch
13.45		Case #6—Multiple myeloma (MM): Treatment of the non-transplant patient Evangelos Terpos, MD, PhD
14.20		Case #7—Emerging options for a patient with non-Hodgkin lymphoma Mathias Rummel, MD, PhD
14.55		Case #8— Current approaches to newly-diagnosed MM: Bone-targeted therapy Evangelos Terpos, MD, PhD
15.30		Concluding remarks